相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression
Venkatrao Vantaku et al.
ONCOGENE (2020)
Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis
Jia Yu Leung et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Structural and functional regulation of lactate dehydrogenase-A in cancer
Mark R. Woodford et al.
FUTURE MEDICINAL CHEMISTRY (2020)
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy
Sruthi Hindupur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor
Tengrui Zhang et al.
CLINICAL EPIGENETICS (2020)
Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion
Sara Monteiro-Reis et al.
CANCERS (2020)
Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
Manuel Castanheira de Oliveira et al.
CANCERS (2020)
DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
Zijian Tian et al.
CANCER CELL INTERNATIONAL (2020)
LncRNAs regulate metabolism in cancer
Wenyu Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Aikaterini F. Giannopoulou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
Ilias Mylonis et al.
CELLS (2019)
LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression
Qun Zhou et al.
BIOSCIENCE REPORTS (2019)
LncRNA PU.1 AS regulates arsenic-induced lipid metabolism through EZH2/Sirt6/SREBP-1c pathway
Zheng Dong et al.
JOURNAL OF ENVIRONMENTAL SCIENCES (2019)
The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
Ana Lameirinhas et al.
GENES (2019)
Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer
Alba Loras et al.
CANCERS (2019)
Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer
Songtao Cheng et al.
CLINICAL SCIENCE (2019)
The cancer driver genes IDH1/2, JARID1C/KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
Soojeong Chang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Cristina Segovia et al.
NATURE MEDICINE (2019)
Connections between metabolism and epigenetics in cancers
Chitra Thakur et al.
SEMINARS IN CANCER BIOLOGY (2019)
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
Zhimin Gu et al.
CANCER DISCOVERY (2019)
BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells
Feng Li et al.
CANCER MEDICINE (2019)
Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
Alba Loras et al.
CANCERS (2019)
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Fabiana Crispo et al.
CELLS (2019)
Oncometabolites: A new insight for oncology
Fatemeh Khatami et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Victor G. Martinez et al.
FRONTIERS IN GENETICS (2019)
Long non-coding RNAs involved in cancer metabolic reprogramming
Hui Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Abraham Pedroza-Torres et al.
FRONTIERS IN ONCOLOGY (2019)
Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a
Xuechao Dong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186
Jun-Jun Zhang et al.
ONCOLOGY RESEARCH (2018)
GSTP1 methylation in cancer: a liquid biopsy biomarker?
Giorgia Gurioli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
Yann Cormerais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway
Qiang Zhu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
Qiongli Su et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Metabolic changes in bladder cancer
Benjamin L. Woolbright et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis
Changkun Huang et al.
ONCOTARGETS AND THERAPY (2018)
Bladder cancer recurrence surveillance by urine metabolomics analysis
A. Loras et al.
SCIENTIFIC REPORTS (2018)
MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
Guiming Zhang et al.
JOURNAL OF CANCER (2018)
Targeting DNA Methyltranferases in Urological Tumors
Angela Marques-Magalhaes et al.
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Emerging roles of long non-coding RNAs in tumor metabolism
Hui Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Metabolic Signaling to the Nucleus in Cancer
Sydney L. Campbell et al.
MOLECULAR CELL (2018)
Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
Austin Yeon et al.
THERANOSTICS (2018)
ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
Yahui Kong et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
MicroRNAs regulate survival in oxygen-deprived environments
Simon G. English et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2018)
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
Vera Miranda-Goncalves et al.
FRONTIERS IN GENETICS (2018)
Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway
Guangyang Yu et al.
JOURNAL OF BONE ONCOLOGY (2018)
Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors
Katerina Duskova et al.
IN VIVO (2018)
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
Iris Lodewijk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells
Junfeng Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use
Barbara Zdzisinska et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2017)
Interplay of mitochondrial metabolism and microRNAs
Julian Geiger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development
C. T. Tsai et al.
ONCOGENE (2017)
The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition
C. Battistelli et al.
ONCOGENE (2017)
Epigenetic therapy in urologic cancers: an update on clinical trials
Ines Faleiro et al.
ONCOTARGET (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma
Fahim Ahmad et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
C. C. Wong et al.
ONCOGENE (2017)
Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α
W. Wan et al.
ONCOGENE (2017)
Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling
Shibo Wei et al.
ONCOLOGY REPORTS (2017)
Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis
Tao Ta et al.
ONCOLOGY REPORTS (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
Lian Dee Ler et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
MacroH2A1.1 cooperates with EZH2 to promote adipogenesis by regulating Wnt signaling
Danyang Wan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway
Junhua Luo et al.
ONCOLOGY LETTERS (2017)
BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases
Adonia E. Papathanassiu et al.
NATURE COMMUNICATIONS (2017)
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San Jose-Eneriz et al.
NATURE COMMUNICATIONS (2017)
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer
Cristina Segovia et al.
ONCOTARGET (2017)
The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
Ran Xu et al.
ONCOTARGET (2017)
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition
Teresa Ezponda et al.
CELL REPORTS (2017)
LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
Haibiao Xie et al.
JOURNAL OF CANCER (2017)
Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
Xing Wang et al.
SCIENTIFIC REPORTS (2017)
Three serum metabolite signatures for diagnosing low-grade and highgrade bladder cancer
Guangguo Tan et al.
SCIENTIFIC REPORTS (2017)
Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma
Viviana Casagrande et al.
SCIENTIFIC REPORTS (2017)
MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1
Peng Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway
Hui-Jin Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy
Marco Tomasetti et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
The p53-inducible long noncoding RNA TRINGS protects cancer cells from necrosis under glucose starvation
Muhammad Riaz Khan et al.
EMBO JOURNAL (2017)
The contemporary role and impact of urine-based biomarkers in bladder cancer
Igor Duquesne et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
Carolyn D. Hurst et al.
CANCER CELL (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
Catherine Leygo et al.
DISEASE MARKERS (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway
Mei Xue et al.
CANCER SCIENCE (2016)
The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer
Yang Zhou et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
Jingjing Pan et al.
CANCER LETTERS (2016)
Metabolic phenotype of bladder cancer
Francesco Massari et al.
CANCER TREATMENT REVIEWS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Economic Burden of Bladder Cancer Across the European Union
Jose Leal et al.
EUROPEAN UROLOGY (2016)
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Marco Sciacovelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Undercover: gene control by metabolites and metabolic enzymes
Jan A. van der Knaap et al.
GENES & DEVELOPMENT (2016)
Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer
Michael I. Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2016)
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Yongcheng Song et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
STAT5 in Cancer and Immunity
Aradhana Rani et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2016)
S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis
Sang Ah Yi et al.
MOLECULAR CELL (2016)
LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress
Xiaowen Liu et al.
NATURE CELL BIOLOGY (2016)
Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells
Wei-Guang Lan et al.
ONCOLOGY REPORTS (2016)
Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription
Aristeidis E. Boukouris et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer
Yi Lu et al.
ONCOTARGETS AND THERAPY (2016)
LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells
Zhen Wei Zou et al.
ONCOTARGET (2016)
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
Fredy O. Beltran-Anaya et al.
FRONTIERS IN PHYSIOLOGY (2016)
Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes
Claudia Berrondo et al.
PLOS ONE (2016)
The role of microRNAs in bladder cancer
Hideki Enokida et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2016)
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
Sharon M. Louie et al.
Cell Chemical Biology (2016)
Genetic and Epigenetic Alterations in Bladder Cancer
Hong-Tao Li et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway
Hongxue Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis
C. Blick et al.
BRITISH JOURNAL OF CANCER (2015)
MicroRNA-138 Regulates Metastatic Potential of Bladder Cancer Through ZEB2
De-Kang Sun et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism
Vanessa R. Conde et al.
EXPERIMENTAL CELL RESEARCH (2015)
EZH2 in Bladder Cancer, a Promising Therapeutic Target
Monica Martinez-Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells
Christiane Rieger et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer
Hui-Jin Li et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Emerging field of metabolomics: Big promise for cancer biomarker identification and drug discovery
Seema Patel et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Metabolomics for laboratory diagnostics
Renata Bujak et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Targeting glycogen metabolism in bladder cancer
Carolyn Ritterson Lew et al.
NATURE REVIEWS UROLOGY (2015)
Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)
Xia Jiang et al.
PLOS ONE (2015)
miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer
Haifeng Wang et al.
TUMOR BIOLOGY (2015)
Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis
Sanaa Eissa et al.
TUMOR BIOLOGY (2015)
Diagnostic and prognostic epigenetic biomarkers in cancer
Pedro Costa-Pinheiro et al.
EPIGENOMICS (2015)
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer
Monica Martinez-Fernandez et al.
ONCOTARGET (2015)
Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer
Monica Martinez-Fernandez et al.
CLINICAL EPIGENETICS (2015)
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
Robert Stoehr et al.
MOLECULAR METABOLISM (2015)
Epigenetic regulation of drug metabolism and transport
Lai Peng et al.
ACTA PHARMACEUTICA SINICA B (2015)
A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis
Xiao Yang et al.
TUMOR BIOLOGY (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
In Vivo Disruption of an Rb-E2F-Ezh2 Signaling Loop Causes Bladder Cancer
Mirentxu Santos et al.
CANCER RESEARCH (2014)
Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway
Zhengkun Li et al.
CANCER SCIENCE (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful Surrogate
Hugh J. Lavery et al.
JOURNAL OF UROLOGY (2014)
Reciprocal Regulation of HIF-1 alpha and LincRNA-p21 Modulates the Warburg Effect
Fan Yang et al.
MOLECULAR CELL (2014)
Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway
Qiang Bu et al.
MOLECULAR MEDICINE REPORTS (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
Bryan M. Wittmann et al.
PLOS ONE (2014)
Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis
Jing-Jing Chuang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer
Tiantian Wang et al.
TUMOR BIOLOGY (2014)
Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion
Mei Xue et al.
TUMOR BIOLOGY (2014)
Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder
Heejeong Lee et al.
VIRCHOWS ARCHIV (2014)
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Ramzi F. Sweis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Paula Lopez-Serra et al.
NATURE COMMUNICATIONS (2014)
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers
Shruti Desai et al.
ONCOTARGET (2014)
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
Xing Jin et al.
ONCOTARGET (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
Urinary biomarkers of bladder cancer: an update and future perspectives
Charles J. Rosser et al.
BIOMARKERS IN MEDICINE (2013)
SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
Seung Min Jeong et al.
CANCER CELL (2013)
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
P. Y. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
The Histone H3 Methyltransferase G9A Epigenetically Activates the Serine-Glycine Synthesis Pathway to Sustain Cancer Cell Survival and Proliferation
Jane Ding et al.
CELL METABOLISM (2013)
Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation
Yiyang Sun et al.
CURRENT CANCER DRUG TARGETS (2013)
miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance
Yen-Hao Chen et al.
DIABETES (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1
Yonghua Han et al.
FEBS LETTERS (2013)
The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10
Gregor Bochenek et al.
HUMAN MOLECULAR GENETICS (2013)
Non-coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome
Leonidas Benetatos et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy
Doreen Kunze et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Lactate Dehydrogenase A in Cancer: A Promising Target for Diagnosis and Therapy
Ping Miao et al.
IUBMB LIFE (2013)
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
Yat-Yuen Lim et al.
JOURNAL OF CELL SCIENCE (2013)
Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach
Juliana Vieira Alberice et al.
JOURNAL OF CHROMATOGRAPHY A (2013)
Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors
Azadeh Ebrahimi et al.
JOURNAL OF NEUROSURGERY (2013)
Low- and High-Grade Bladder Cancer Determination via Human Serum-Based Metabolomics Approach
Navneeta Bansal et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Urinary Metabotyping of Bladder Cancer Using Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry
Kishore Kumar Pasikanti et al.
JOURNAL OF PROTEOME RESEARCH (2013)
miRNA-100 Inhibits Human Bladder Urothelial Carcinogenesis by Directly Targeting mTOR
Chuanliang Xu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Aberrant expression of microRNAs in bladder cancer
Hirofumi Yoshino et al.
NATURE REVIEWS UROLOGY (2013)
Holistic metabonomic profiling of urine affords potential early diagnosis for bladder and kidney cancers
Zhenzhen Huang et al.
METABOLOMICS (2013)
miR-143 regulates hexokinase 2 expression in cancer cells
A. Peschiaroli et al.
ONCOGENE (2013)
miRNAs link metabolic reprogramming to oncogenesis
Maria Hatziapostolou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
Guenter Niegisch et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
Jiyung Shin et al.
CELL REPORTS (2013)
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review
Agnieszka Smolinska et al.
ANALYTICA CHIMICA ACTA (2012)
Quantitative determination of taurine and related biomarkers in urine by liquid chromatography-tandem mass spectrometry
Sanjeewa Gamagedara et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
NMR-based Metabolomic Analysis of Human Bladder Cancer
Ming Cao et al.
ANALYTICAL SCIENCES (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Feedback networks between microRNAs and epigenetic modifications in urological tumors
Julia Liep et al.
EPIGENETICS (2012)
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers
Raju Kandimalla et al.
EUROPEAN UROLOGY (2012)
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression
Xiang Fei et al.
FEBS LETTERS (2012)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
Ruth L. Vinall et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-mediated Deacetylation
William C. Hallows et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A
Imari Mimura et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Matthew F. Barber et al.
NATURE (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation
Jiangbin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Best practice in the treatment of nonmuscle invasive bladder cancer
Anastasios Anastasiadis et al.
THERAPEUTIC ADVANCES IN UROLOGY (2012)
Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
Nagireddy Putluri et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Cancer epigenetics: linking basic biology to clinical medicine
Hsing-Chen Tsai et al.
CELL RESEARCH (2011)
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert et al.
CLINICAL CANCER RESEARCH (2011)
Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
Erik D. Wiklund et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Bladder Cancer Determination Via Two Urinary Metabolites: A Biomarker Pattern Approach
Zhenzhen Huang et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth
Lei Lv et al.
MOLECULAR CELL (2011)
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme
Amparo Wolf et al.
NEUROBIOLOGY OF DISEASE (2011)
Negative regulation of the tumor suppressor p53 gene by microRNAs
M. Kumar et al.
ONCOGENE (2011)
SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
E. L. Bell et al.
ONCOGENE (2011)
MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24
Yan Cao et al.
TUMOR BIOLOGY (2011)
Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature
Cauberg C. C. Evelyne et al.
INDIAN JOURNAL OF UROLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by H-1 NMR spectroscopy
Shatakshi Srivastava et al.
CANCER BIOMARKERS (2010)
Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
Erika M. Wolff et al.
CANCER RESEARCH (2010)
Epigenetic Regulation of Vitamin D 24-Hydroxylase/CYP24A1 in Human Prostate Cancer
Wei Luo et al.
CANCER RESEARCH (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer
Kishore Kumar Pasikanti et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients
Jeong-Whun Kim et al.
METABOLOMICS (2010)
SIRT6 A master epigenetic gatekeeper of glucose metabolism
Lei Zhong et al.
TRANSCRIPTION-AUSTIN (2010)
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
Lars Dyrskjot et al.
CANCER RESEARCH (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Metabolic phenotyping in health and disease
Elaine Holmes et al.
CELL (2008)
Epigenetic Regulation of Genes Encoding Drug-Metabolizing Enzymes and Transporters; DNA Methylation and Other Mechanisms
Ichiro Ieiri et al.
CURRENT DRUG METABOLISM (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry
Haleem J. Issaq et al.
JOURNAL OF UROLOGY (2008)
The mammalian epigenome
Bradley E. Bernstein et al.
CELL (2007)
The role of chromatin during transcription
Bing Li et al.
CELL (2007)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer
Steven T. Okino et al.
CANCER RESEARCH (2006)
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Akt-dependent transformation: there is more to growth than just surviving
DR Plas et al.
ONCOGENE (2005)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
JWF Catto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas
T Nakagawa et al.
JOURNAL OF UROLOGY (2005)
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel
E Dulaimi et al.
CLINICAL CANCER RESEARCH (2004)
Hypoxia-inducible factor 1α expression correlates with angiogenesis and unfavorable prognosis in bladder cancer
VE Theodoropoulos et al.
EUROPEAN UROLOGY (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress
HP Harding et al.
MOLECULAR CELL (2003)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder
F Kimura et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
